DK0627429T3 - Loracarbefisopropanolat og fremgangsmåde til omdannelse af loracarbefisopropanolat til loracarbefmonohydrat - Google Patents
Loracarbefisopropanolat og fremgangsmåde til omdannelse af loracarbefisopropanolat til loracarbefmonohydratInfo
- Publication number
- DK0627429T3 DK0627429T3 DK94303942T DK94303942T DK0627429T3 DK 0627429 T3 DK0627429 T3 DK 0627429T3 DK 94303942 T DK94303942 T DK 94303942T DK 94303942 T DK94303942 T DK 94303942T DK 0627429 T3 DK0627429 T3 DK 0627429T3
- Authority
- DK
- Denmark
- Prior art keywords
- loracarbefisopropanolate
- converting
- loracarbef monohydrate
- loracarbef
- crystalline
- Prior art date
Links
- GPYKKBAAPVOCIW-HSASPSRMSA-N (6r,7s)-7-[[(2r)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;hydrate Chemical compound O.C1([C@H](C(=O)N[C@@H]2C(N3C(=C(Cl)CC[C@@H]32)C(O)=O)=O)N)=CC=CC=C1 GPYKKBAAPVOCIW-HSASPSRMSA-N 0.000 title abstract 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000012453 solvate Substances 0.000 abstract 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 abstract 1
- 229960001977 loracarbef Drugs 0.000 abstract 1
- 150000004682 monohydrates Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
- C07D463/16—Nitrogen atoms
- C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
- C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/072,204 US5399686A (en) | 1993-06-04 | 1993-06-04 | Loracarbef isopropanolate and a process for converting loracarbef isopropanolate to loracarbef monohydrate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0627429T3 true DK0627429T3 (da) | 1999-10-11 |
Family
ID=22106211
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK94303942T DK0627429T3 (da) | 1993-06-04 | 1994-06-01 | Loracarbefisopropanolat og fremgangsmåde til omdannelse af loracarbefisopropanolat til loracarbefmonohydrat |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US5399686A (da) |
| EP (1) | EP0627429B1 (da) |
| JP (1) | JP3442861B2 (da) |
| KR (1) | KR100308746B1 (da) |
| AT (1) | ATE178328T1 (da) |
| BR (1) | BR9402148A (da) |
| CA (1) | CA2124999C (da) |
| DE (1) | DE69417472T2 (da) |
| DK (1) | DK0627429T3 (da) |
| ES (1) | ES2129106T3 (da) |
| FI (1) | FI108133B (da) |
| GR (1) | GR3030211T3 (da) |
| HU (1) | HUT67911A (da) |
| IL (1) | IL109869A (da) |
| SI (1) | SI0627429T1 (da) |
| TW (1) | TW492968B (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5399686A (en) * | 1993-06-04 | 1995-03-21 | Eli Lilly And Company | Loracarbef isopropanolate and a process for converting loracarbef isopropanolate to loracarbef monohydrate |
| US5550231A (en) * | 1993-06-15 | 1996-08-27 | Eli Lilly And Company | Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof |
| US5580977A (en) * | 1995-03-01 | 1996-12-03 | Eli Lilly And Company | Process for preparing loracarbef monohydrate |
| GB9717629D0 (en) | 1997-08-21 | 1997-10-22 | Johnson Matthey Plc | Removal of residual organic solvents |
| KR100519650B1 (ko) * | 1999-02-05 | 2005-10-07 | 제일모직주식회사 | 점도가 균일한 폴리아믹산의 제조방법 |
| AU2003283624A1 (en) * | 2002-11-21 | 2004-06-15 | Ranbaxy Laboratories Limited | Monohydrate solvates of loracarbef |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3531481A (en) * | 1969-04-21 | 1970-09-29 | Lilly Co Eli | Method for manufacture of crystalline cephalosporin |
| US3502663A (en) * | 1969-04-21 | 1970-03-24 | Lilly Co Eli | Crystalline cephalosporin,method for its manufacture |
| US4775751A (en) * | 1985-06-03 | 1988-10-04 | Eli Lilly & Company | Process for cephalexin hydrochloride alcoholates |
| CA1334970C (en) * | 1987-10-06 | 1995-03-28 | Carol Elaine Pasini | Crystalline .beta.-lactam hydrate |
| US4977257A (en) * | 1988-11-14 | 1990-12-11 | Eli Lilly And Company | DMF solvates of a β-lactam antibiotic |
| CA2002596A1 (en) * | 1988-11-14 | 1990-05-14 | Thomas M. Eckrich | Hydrates of b-lactam antibiotic |
| US5399686A (en) * | 1993-06-04 | 1995-03-21 | Eli Lilly And Company | Loracarbef isopropanolate and a process for converting loracarbef isopropanolate to loracarbef monohydrate |
| US5352782A (en) * | 1993-06-04 | 1994-10-04 | Eli Lilly And Company | Process for preparing crystalline β-lactam monohydrate |
-
1993
- 1993-06-04 US US08/072,204 patent/US5399686A/en not_active Expired - Lifetime
-
1994
- 1994-06-01 BR BR9402148A patent/BR9402148A/pt not_active Application Discontinuation
- 1994-06-01 DE DE69417472T patent/DE69417472T2/de not_active Expired - Fee Related
- 1994-06-01 AT AT94303942T patent/ATE178328T1/de not_active IP Right Cessation
- 1994-06-01 ES ES94303942T patent/ES2129106T3/es not_active Expired - Lifetime
- 1994-06-01 EP EP94303942A patent/EP0627429B1/en not_active Expired - Lifetime
- 1994-06-01 SI SI9430256T patent/SI0627429T1/xx not_active IP Right Cessation
- 1994-06-01 DK DK94303942T patent/DK0627429T3/da active
- 1994-06-01 TW TW083105010A patent/TW492968B/zh not_active IP Right Cessation
- 1994-06-02 KR KR1019940012342A patent/KR100308746B1/ko not_active IP Right Cessation
- 1994-06-02 CA CA002124999A patent/CA2124999C/en not_active Expired - Fee Related
- 1994-06-02 IL IL109869A patent/IL109869A/en not_active IP Right Cessation
- 1994-06-03 HU HU9401673A patent/HUT67911A/hu unknown
- 1994-06-03 JP JP12229794A patent/JP3442861B2/ja not_active Expired - Fee Related
- 1994-06-03 FI FI942631A patent/FI108133B/fi not_active IP Right Cessation
- 1994-12-01 US US08/347,759 patent/US5672700A/en not_active Expired - Fee Related
-
1999
- 1999-05-13 GR GR990401296T patent/GR3030211T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2124999A1 (en) | 1994-12-05 |
| KR100308746B1 (ko) | 2001-11-30 |
| DE69417472D1 (de) | 1999-05-06 |
| EP0627429A1 (en) | 1994-12-07 |
| CA2124999C (en) | 2004-08-10 |
| HUT67911A (en) | 1995-05-29 |
| ES2129106T3 (es) | 1999-06-01 |
| FI942631A0 (fi) | 1994-06-03 |
| HU9401673D0 (en) | 1994-09-28 |
| TW492968B (en) | 2002-07-01 |
| JP3442861B2 (ja) | 2003-09-02 |
| SI0627429T1 (en) | 1999-10-31 |
| GR3030211T3 (en) | 1999-08-31 |
| US5399686A (en) | 1995-03-21 |
| FI108133B (fi) | 2001-11-30 |
| US5672700A (en) | 1997-09-30 |
| IL109869A0 (en) | 1994-10-07 |
| JPH06345762A (ja) | 1994-12-20 |
| FI942631A (fi) | 1994-12-05 |
| IL109869A (en) | 1998-06-15 |
| DE69417472T2 (de) | 1999-08-19 |
| KR950000703A (ko) | 1995-01-03 |
| EP0627429B1 (en) | 1999-03-31 |
| ATE178328T1 (de) | 1999-04-15 |
| BR9402148A (pt) | 1994-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9200817A (es) | Derivados de piranil cianoguanidina y proceso para su preparacion. | |
| FI101376B1 (fi) | Menetelmä 3-bentsyyliamino-2-fenyylipiperidiinijohdannaisten valmistamiseksi | |
| DK0627429T3 (da) | Loracarbefisopropanolat og fremgangsmåde til omdannelse af loracarbefisopropanolat til loracarbefmonohydrat | |
| BR9105424A (pt) | Processo para preparacao de um composto pesticida | |
| DK0782996T3 (da) | Fremgangsmåde til fremstilling af N-biphenylmethylthiadiazolinderivat eller salt deraf og mellemprodukt til fremstilling af | |
| DK0627430T3 (da) | Fremgangsmåde til omdannelse af loracarbef-dihydrat til loracarbefmonohydrat | |
| DK0665221T3 (da) | Vitamin D derivat og fremgangsmåde til fremstilling af dette | |
| DK0506235T3 (da) | Glyceraldehyd-3-pentanid og fremgangsmåde til fremstilling af samme | |
| MX9706606A (es) | Procedimiento para la preparacion del monohidrato de loracarbef. | |
| ES2164258T3 (es) | Procedimiento de preparacion de derivados de carbamoilmetilurea. | |
| DK504788A (da) | Fremgangsmaade til fremstilling af makrolidforbindelser | |
| FI863897A (fi) | Kemiskt foerfarande. | |
| FI944967A (fi) | Menetelmiä proteolyyttisen entsyymin inhibiittoreina käyttökelpoisten sakkariinijohdannaisten ja niiden välituotteiden valmistamiseksi |